These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10846590)

  • 21. Antiretroviral drug resistance and resistance testing.
    Gallant JE
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
    Vercauteren J; Vandamme AM
    Antiviral Res; 2006 Sep; 71(2-3):335-42. PubMed ID: 16782210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P; Lazzarin A
    Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 drug resistance assays in clinical management.
    Martinez-Picado J; D'Aquila R
    AIDS Clin Care; 1998 Nov; 10(11):81-5, 87-8. PubMed ID: 11365861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of different systems for interpreting results of genotypic antiretroviral drug resistance tests.
    García F; Palomares JC; Martínez NM; Alvarez M; Suarez S; García F; Rodríguez JM; Quero JH; del Carmen Maroto M
    Antivir Ther; 2003 Jun; 8(3):251-2. PubMed ID: 12924543
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV resistance testing: more questions than answers.
    Mirken B
    AIDS Treat News; 1997 Nov; (No 283):3-5. PubMed ID: 11364909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV resistance testing: a new clinical tool.
    Jorden VS; Paul SM
    N J Med; 2000 Oct; 97(10):33-8. PubMed ID: 11064565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview on HIV-1-related drug resistance: from theory to clinical practice.
    Moroni M; Balotta C; Rusconi S
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):15-8. PubMed ID: 9689573
    [No Abstract]   [Full Text] [Related]  

  • 30. A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off?
    Simcock M; Sendi P; Ledergerber B; Keller T; Schüpbach J; Battegay M; Günthard HF;
    Antivir Ther; 2006; 11(3):305-14. PubMed ID: 16759046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpretation of resistance assay results.
    Miller V
    Antivir Ther; 2001; 6 Suppl 2():1-9. PubMed ID: 11678473
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding HIV phenotypic resistance testing: usefulness in managing treatment-experienced patients.
    MacArthur RD
    AIDS Rev; 2009; 11(4):223-30. PubMed ID: 19940949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 35. New data brings resistance testing closer to routine clinical use.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(3):6. PubMed ID: 11810872
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance tests: what do clinical trials tell us?
    Price N; Smit E; Pillay D
    J HIV Ther; 2002 Nov; 7(4):80-6. PubMed ID: 12733605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems.
    Pasomsub E; Sukasem C; Sungkanuparph S; Kijsirikul B; Chantratita W
    Jpn J Infect Dis; 2010 Mar; 63(2):87-94. PubMed ID: 20332568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance testing.
    Munk B
    Posit Aware; 1997; 8(4):35-7. PubMed ID: 11364486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated European recommendations for the clinical use of HIV drug resistance testing.
    Vandamme AM; Sönnerborg A; Ait-Khaled M; Albert J; Asjo B; Bacheler L; Banhegyi D; Boucher C; Brun-Vézinet F; Camacho R; Clevenbergh P; Clumeck N; Dedes N; De Luca A; Doerr HW; Faudon JL; Gatti G; Gerstoft J; Hall WW; Hatzakis A; Hellmann N; Horban A; Lundgren JD; Kempf D; Miller M; Miller V; Myers TW; Nielsen C; Opravil M; Palmisano L; Perno CF; Phillips A; Pillay D; Pumarola T; Ruiz L; Salminen M; Schapiro J; Schmidt B; Schmit JC; Schuurman R; Shulse E; Soriano V; Staszewski S; Vella S; Youle M; Ziermann R; Perrin L
    Antivir Ther; 2004 Dec; 9(6):829-48. PubMed ID: 15651743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.
    Holguín A; Ramirez de Arellano E; Rivas P; Soriano V
    AIDS Rev; 2006; 8(2):98-107. PubMed ID: 16848277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.